Na Su

Cefoperazone-sulbactam and risk of coagulation disorders or bleeding: a retrospective cohort study

Wen Wang, Yanmei Liu, Chuan Yu et al. · Expert Opinion on Drug Safety · 2020 · 61 citations

Medicine, Hematology, Pharmacology +14

Bifunctional Naphtho[2,3-<i>d</i>][1,2,3]triazole-4,9-dione Compounds Exhibit Antitumor Effects In Vitro and In Vivo by Inhibiting Dihydroorotate Dehydrogenase and Inducing Reactive Oxygen Species Production

Zeping Zuo, Xiaocong Liu, Xinying Qian et al. · Journal of Medicinal Chemistry · 2020 · 52 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +16

miR‐548c‐5p inhibits colorectal cancer cell proliferation by targeting PGK1

Jianxin Ge, Jun Li, Na Su et al. · Journal of Cellular Physiology · 2019 · 43 citations

Medicine, Cancer Biology, Oncology +17

Safety of ezetimibe in lipid-lowering treatment: systematic review and meta-analysis of randomised controlled trials and cohort studies

Yang Wang, Shipeng Zhan, Heyue Du et al. · BMJ Medicine · 2022 · 38 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Repression of LSD1 potentiates homologous recombination-proficient ovarian cancer to PARP inhibitors through down-regulation of BRCA1/2 and RAD51

Lei Tao, Yue Zhou, Xiangyu Pan et al. · Nature Communications · 2023 · 33 citations · Full text

Life Sciences, Molecular Biology, Oncology +17